Machine learning classification of cellular states based on the impedance features derived from microfluidic

Jian Wei1, Wenbing Gao1, Xinlong Yang1

  • 1College of Information Science and Technology, Beijing University of Chemical Technology, No. 15 North 3rd Ring Road, Chaoyang District, Beijing 100029, China.

Biomicrofluidics
|January 26, 2024
PubMed

Insights

Machine learning combined with microfluidic impedance flow cytometry (IFC) accurately classifies drug-treated cells. This approach enables label-free, high-throughput analysis of cell states, aiding cancer drug development.

Area of Science:

  • Cell Biology
  • Biophysics
  • Computational Biology

Background:

  • Mitosis is essential for cell division, and its disruption is a target for anti-cancer drugs.
  • Drug-induced cell cycle arrest or apoptosis are key outcomes in cancer therapy.
  • Label-free, high-throughput single-cell analysis is crucial for understanding drug effects.

Purpose of the Study:

  • To apply machine learning (ML) with microfluidic impedance flow cytometry (IFC) for label-free classification of drug-treated tumor cells.
  • To differentiate between various cell states, including G1/S, G2/M arrest, and apoptosis.
  • To classify subpopulations of cells, including drug-resistant ones.

Main Methods:

  • Utilized IFC to measure electrophysiological parameters of single cells.
  • Extracted impedance amplitudes and phases as features for ML model training.
  • Employed a deep neural network (DNN) model with optimized structures for cell type and drug-specific classification.

Main Results:

  • Achieved high classification accuracies for H1650 and HeLa cells, differentiating between G1/S, G2/M arrest, and apoptosis states.
  • Demonstrated high accuracy (approaching 100%) in classifying viable vs. non-viable cells and G2/M arrest vs. apoptosis in vinblastine-treated HeLa cells.
  • Successfully classified three subpopulations (drug-insensitive, G2/M arrest, apoptosis) in taxol or vinblastine-treated cells.

Conclusions:

  • ML combined with IFC provides a powerful, label-free method for high-throughput single-cell analysis of drug effects.
  • The DNN model effectively classifies complex cell states induced by anti-cancer drugs.
  • This approach has significant potential for drug discovery and personalized medicine by identifying drug responses and resistance mechanisms.